You are here: Home » Companies » News
Business Standard

Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit

The kit is validated by the Indian Council of Medical Research (ICMR) and much more advanced than other RT PCR tests, the drug firm said

Cipla | Coronavirus | Rapid Antigen Testing

Press Trust of India  |  New Delhi 

Cipla, Cipla logo, Cipla headquarters
An employee works at the reception area of Cipla at its headquarters in Mumbai. Photo: Reuters

Drug major on Tuesday said it has launched a COVID-19 RT PCR testing kit in the country in partnership with firm Genes2Me.

With the launch of the "RT-Direct multiplex COVID-19 RT PCR" test kit, the Mumbai-based drug firm is expanding its offerings, it said in a regulatory filing.

will be responsible for the distribution of RT Direct kits in India and has commenced supply of the same, it added.

The kit is validated by the Indian Council of Medical Research (ICMR) and much more advanced than other RT PCR tests, the drug firm said.

RT-Direct test protocol does not require any RNA extraction process, making it faster and helping deliver results in just 45 minutes, it added.

It will also increase the throughput of any testing lab by threefold compared to the normal RT-PCR test protocol time of 120-150 minutes, noted.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, May 10 2022. 12:14 IST